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We have extended the existing method of ionic
dialysance measurement in the diffusive regime to the
highly convective online hemodiafiltration regimen by
developing a method that is applicable to various modes of
substitution (post-, pre-, and mixed dilution). In contrast
to other theoretical methods, all required quantities can be
measured to a high precision without the knowledge of
blood and dialyzer properties. In our in vivo study, we have
validated our approach by taking the blood-side urea
clearance as a reference. We did not intend to do a
systematic analysis of the dependence of the dialysance on
the dialysis conditions.
In their in vitro experiment, Ficheux et al.2,3 evaluated
the impact of increasing ultrafiltration flow and varying
site of substitution on total ionic clearance. They nicely
illustrated that ionic dialysance is linearly correlated with
ultrafiltration flow. In contrast to our study, they did not
provide a technically feasible method to measure ionic
dialysance in vivo as their model either requires the
measurement of blood-side conductivity or the a priori
knowledge of the dialysance without online substitution.
In our study, 26 measurements have been omitted due
to errors in the sampling or processing of the correspond-
ing blood reference samples. During our experimental
study, size and shape of the transient conductivity change
were varied to determine their optimal values. From the
statistical analysis of the measurement, error threshold
values for these parameters were fixed. In 22 cases, the
conductivity change was suboptimal and the correspond-
ing measurements were excluded from the final analysis.
No individual measurements were excluded a posteriori as
statistical outliers.
We conclude that in contrast to what the authors of this
letter claim, our modeling approach is quite original. It
allows the determination of the ionic dialysis in online
hemodiafiltration treatments by measurements on the
dialysate side alone. This approach provides a safe and
reliable tool to evaluate routinely in clinic the dialysis dose
delivered by online HDF.
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To the Editor: I read with interest the study by Reungjui
et al.1,2 and the accompanied editorial published in the same
issue of Kidney International. The study by Reungjui et al.
included 20–24 rats divided into four groups, with two of
them being subjected to thiazide diuretics. The authors
convincingly show that low kidney function and glomerular
and tubular injury manifest more commonly in thiazide-
treated rats, an effect that cannot be explained by
hypokalemia alone. Various credible explanations were also
provided and are all well taken. However, in the conclusion
section as well as in the editorial that accompanied this
article, the authors make a connection between the
pathological findings in rats and the results of various
clinical hypertensive studies done in humans. Although I do
not disagree or agree with the authors’ interpretations and
arguments regarding the design and outcome of these cited
clinical trials, I find it very puzzling to make a link between
pathological findings in rats taking thiazide diuretics and
clinical studies that used thiazides in humans. Current
knowledge indicates that rat kidneys differ not only from
humans but there is also intraspecies variability.3,4 A few
other questions come to mind. Assuming that the rats
actually drank all the thiazide-loaded water and accordingly
received 1.5–1.75 mg thiazide/day, how does this dose
translate to clinical practice or to the dose used in the
ALLHAT or AASK trials? What is the equivalent of 20 weeks
of rat age in human life? Can the same findings be
reproduced if another rat species was used?
Basic science research continues to be the best tool to
build breakthrough clinical research, but until studies
dedicated to examine the effect of chronic thiazide use on
histological findings and/or kidney function in humans
become available, I think extrapolating from animal studies
risks unwarranted changes in clinical practices and public
confusion.
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